30 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
28151653	35	Full Sequence Amino Acid Scanning of¿-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor.	State University of New York
26492514	56	Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.	University of Minnesota
25116076	14	Exploring the influence of the protein environment on metal-binding pharmacophores.	University of California
24290062	142	Small molecule inhibitors of anthrax lethal factor toxin.	Microbiotix
22960696	5	D-proline-based peptidomimetic inhibitors of anthrax lethal factor.	TBA
22342144	72	Antidotes to anthrax lethal factor intoxication. Part 3: Evaluation of core structures and further modifications to the C2-side chain.	Panthera Biopharma
20155918	72	Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.	Microbiotix
17485504	4	Amiodarone and bepridil inhibit anthrax toxin entry into host cells.	University of California
18314330	4	Inhibitors of anthrax lethal factor based upon N-oleoyldopamine.	Purdue University
22082667	67	Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.	Microbiotix
21334206	39	Antidotes to anthrax lethal factor intoxication. Part 2: structural modifications leading to improved in vivo efficacy.	Panthera Biopharma
21189019	22	Identifying chelators for metalloprotein inhibitors using a fragment-based approach.	University of California
20864339	29	Antidotes to anthrax lethal factor intoxication. Part 1: Discovery of potent lethal factor inhibitors with in vivo efficacy.	Panthera Biopharma
18378717	4	In vivo efficacy of beta-cyclodextrin derivatives against anthrax lethal toxin.	National Institute of Allergy and Infectious Diseases
20045647	35	Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.	Institute For Medical Research
19359184	131	Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.	Institute For Medical Research
17574849	7	Inhibitors of anthrax lethal factor.	Purdue University
28927803	9	In-cell production of a genetically-encoded library based on the ?-defensin RTD-1 using a bacterial expression system.	University of Southern California
29198864	29	Small molecule inhibitors of anthrax edema factor.	Hawaii Biotech
27474803	20	In silico binding analysis and SAR elucidations of newly designed benzopyrazine analogs as potent inhibitors of thymidine phosphorylase.	Universiti Teknologi Mara (Uitm)
8524985	69	D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs.	Case Western Reserve University
17215127	12	Crystal structure of the PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism.	University of North Carolina At Chapel Hill
18318469	75	Discovery of a New Class of Potent, Selective, and Orally Bioavailable CRTH2 (DP2) Receptor Antagonists for the Treatment of Allergic Inflammatory Diseases.	Merck Serono
18318467	9	Arginine binding motifs: design and synthesis of galactose-derived arginine tweezers as galectin-3 inhibitors.	Lund University
18314943	27	Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-beta Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-beta Receptor Type I Inhibitor as Antitumor Agent.	Eli Lilly